Our peptide therapies are designed to complement your broader care at Modera - whether that is a medical weight loss program, chronic care management, functional medicine evaluation, or general primary care
These medications may be dispensed by state-licensed 503A compounding pharmacies as part of personalized care
"I truly believe that when these amylin [drugs] launch, we can have that, what I've described as an iPhone moment, because patients are so aware of the experience they have on the GLP-1s, and once you launch a new modality that gives you a better experience, people will queue up to get access to that new weight loss medication rather than staying on the more cumbersome medicines," said Zealand CEO Adam Steensberg
Our premium peptide collection combines the restorative power of BPC-157, TB-500, and GHK-Cu into one elevated wellness experience